Saskia Ditisheim1, Nicolas Fournier, Pascal Juillerat, Valerie Pittet, Pierre Michetti, Cem Gabay, Axel Finckh. 1. *Clinique La Colline and Division of Gastroenterology and Hepatology, University Hospital of Geneva, Geneva, Switzerland; †Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland; ‡Division of Gastroenterology, Clinic for Visceral Surgery and Medicine, Bern University Hospital, Bern, Switzerland; §Gastroenterology La Source-Beaulieu and Division of Gastroenterology and Hepatology, CHUV, Lausanne, Switzerland; and ‖Division of Rheumatology, University Hospital of Geneva, Geneva, Switzerland.
Abstract
BACKGROUND: Inflammatory bowel diseases (IBD) are systemic conditions that commonly display extraintestinal manifestations. Inflammatory articular disease (IAD: axial or peripheral) is the most common extraintestinal manifestation. The aim of this study was to evaluate the prevalence and the clinical characteristics associated with IAD in patients with IBD. METHODS: We analyzed patients enrolled in the Swiss IBD cohort study. IAD was defined as persistent or recurrent joint pain with an inflammatory pattern (night pain, progressive relief during the day, morning stiffness lasting at least 30 minutes) or the presence of arthritis as diagnosed by the physicians. A multivariate logistic regression was performed to analyze which disease characteristics were independently associated with the presence of IAD. RESULTS: A total of 2353 patients with IBD, 1359 with Crohn's disease, and 994 with ulcerative colitis (UC) were included. Forty-four percent of patients fulfilled the criteria for IAD, whereas 14.5% presented with other extraintestinal manifestations. IAD was associated with Crohn's disease, with female sex, with older age, and generally in patients with more active intestinal disease. Only in UC, IAD was further associated with tobacco smoking and with increasing body mass index. CONCLUSIONS: This population of patients with IBD displays a high prevalence of IAD. IAD was more strongly associated with Crohn's disease than UC. Other risk factors for IAD were female sex, advanced age, active digestive disease, and tobacco consumption in patients with UC, which is interesting given the established association between smoking and other inflammatory arthritides.
BACKGROUND:Inflammatory bowel diseases (IBD) are systemic conditions that commonly display extraintestinal manifestations. Inflammatory articular disease (IAD: axial or peripheral) is the most common extraintestinal manifestation. The aim of this study was to evaluate the prevalence and the clinical characteristics associated with IAD in patients with IBD. METHODS: We analyzed patients enrolled in the Swiss IBD cohort study. IAD was defined as persistent or recurrent joint pain with an inflammatory pattern (night pain, progressive relief during the day, morning stiffness lasting at least 30 minutes) or the presence of arthritis as diagnosed by the physicians. A multivariate logistic regression was performed to analyze which disease characteristics were independently associated with the presence of IAD. RESULTS: A total of 2353 patients with IBD, 1359 with Crohn's disease, and 994 with ulcerative colitis (UC) were included. Forty-four percent of patients fulfilled the criteria for IAD, whereas 14.5% presented with other extraintestinal manifestations. IAD was associated with Crohn's disease, with female sex, with older age, and generally in patients with more active intestinal disease. Only in UC, IAD was further associated with tobacco smoking and with increasing body mass index. CONCLUSIONS: This population of patients with IBD displays a high prevalence of IAD. IAD was more strongly associated with Crohn's disease than UC. Other risk factors for IAD were female sex, advanced age, active digestive disease, and tobacco consumption in patients with UC, which is interesting given the established association between smoking and other inflammatory arthritides.
Authors: M Severs; S J H van Erp; M E van der Valk; M J J Mangen; H H Fidder; M van der Have; A A van Bodegraven; D J de Jong; C J van der Woude; M J L Romberg-Camps; C H M Clemens; J M Jansen; P C van de Meeberg; N Mahmmod; C Y Ponsioen; C Bolwerk; J R Vermeijden; M J Pierik; P D Siersema; M Leenders; A E van der Meulen-de Jong; G Dijkstra; B Oldenburg Journal: J Crohns Colitis Date: 2015-12-30 Impact factor: 9.071
Authors: Tom Van de Wiele; Jens T Van Praet; Massimo Marzorati; Michael B Drennan; Dirk Elewaut Journal: Nat Rev Rheumatol Date: 2016-06-16 Impact factor: 20.543
Authors: Alicia Algaba; Iván Guerra; Elena Ricart; Eva Iglesias; Miriam Mañosa; Javier P Gisbert; Jordi Guardiola; Miguel Mínguez; Beatriz Castro; Ruth de Francisco; Pilar Nos; Federico Bertoletti; Francisco Mesonero; Jesús Barrio; María Dolores Martín-Arranz; Xavier Calvet; Santiago García-López; Beatriz Sicilia; Gillermo Alcaín; María Esteve; Lucía Márquez; Marta Piqueras; Laura Jiménez; José L Perez-Calle; Luis Bujanda; Mariana García-Sepulcre; Alejandra Fernández; Irene Moraleja; Rufo Humberto Lorente; Orlando García-Bosch; Ana Lambán; Isabel Blázquez; Esther Rodríguez; José M Huguet; Alfredo J Lucendo; Pedro Almela; David Busquets; Patricia Ramírez de la Piscina; Marcela Pérez; Eugeni Domenech; Fernando Bermejo Journal: Dig Dis Sci Date: 2020-07-15 Impact factor: 3.199
Authors: Gilaad G Kaplan; Eric I Benchimol; M Ellen Kuenzig; Mohsen Sadatsafavi; J Antonio Aviña-Zubieta; Rebecca M Burne; Michal Abrahamowicz; Marie-Eve Beauchamp Journal: Clin Epidemiol Date: 2018-07-12 Impact factor: 4.790